Récepteur IL
Les récepteurs de l'interleukine (récepteurs IL) sont un groupe de récepteurs qui se lient aux interleukines, une famille de cytokines jouant des rôles essentiels dans la régulation du système immunitaire, l'inflammation et l'hématopoïèse. La dérégulation de la signalisation des interleukines est associée à diverses maladies inflammatoires et auto-immunes, ce qui rend les récepteurs IL des cibles critiques pour les interventions thérapeutiques. Les antagonistes des récepteurs IL sont explorés pour le traitement de conditions telles que la polyarthrite rhumatoïde, le psoriasis et les maladies inflammatoires de l'intestin. Chez CymitQuimica, nous offrons une gamme de modulateurs de récepteurs IL de haute qualité pour soutenir vos recherches en signalisation des cytokines, immunologie et thérapie des maladies inflammatoires.
124 produits trouvés pour "Récepteur IL".
Filtrer par
Pourcentage de pureté
0
100
|
0
|
50
|
90
|
95
|
100
- Tri par prix ascendant
- Tri par prix descendant
- Puretés inférieures
- Puretés supérieures
- Livraison estimée la plus rapide
Canakinumab
CAS :Canakinumab: Human IL-1β antibody, anti-inflammatory, treats gout & coronary disease, IC50 of 43.6 pM (human), 40.8 pM (monkey).Degré de pureté :98.8%Couleur et forme :Transparent LiquidMasse moléculaire :145.18 kDa (Predicted)Daclizumab
CAS :Daclizumab (Zenapax), a humanized antibody, blocks IL-2 by targeting CD25, used in multiple sclerosis.Degré de pureté :SDS-PAGE:95% SEC-HPLC:99.99%Couleur et forme :Transparent LiquidMasse moléculaire :144.12 kDa (Predicted)Dectrekumab
CAS :Dectrekumab (QAX576) is a humanized monoclonal antibody targeting IL-13.Degré de pureté :96.5% (SDS-PAGE); 97.1% (SEC-HPLC) - 96.5% (SDS-PAGE); 97.1% (SEC-HPLC)Couleur et forme :LiquidMasse moléculaire :146.27 kDa (Predicted)MyD88-IN-1
CAS :MyD88-IN-1: Potent MyD88 inhibitor with anti-inflammatory effects, blocking NF-κB and TLR/IL-1 pathways; potential for cancer and inflammation treatment.Formule :C23H24N6O7SDegré de pureté :99.99%Couleur et forme :SoildMasse moléculaire :528.54CNTO 607
CNTO 607 (Anti-IL-13 Antibody) is a humanized antibody targeting IL-13, useful for studying inflammation.Degré de pureté :98% (SDS-PAGE); 98.3% (SEC-HPLC) - 98% (SDS-PAGE); 98.3% (SEC-HPLC)Couleur et forme :Transparent LiquidMasse moléculaire :145.11 kDa (Predicted)Ziltivekimab
CAS :Ziltivekimab (MEDI 5117) is a CHO-expressed humanized monoclonal antibody targeting IL-6/IFNb2 for use in immune system diseases.Degré de pureté :97.2% (SDS-PAGE); 98.9% (SEC-HPLC) - 97.9% (SDS-PAGE); 97.3% (SEC-HPLC)Couleur et forme :Transparent LiquidMasse moléculaire :145.39 kDa (Predicted)Guselkumab
CAS :Guselkumab (CNTO 1959) is a recombinant human IgG1 monoclonal antibody targeting the IL-23p19 subunit.Degré de pureté :SDS-PAGE:95% SEC-HPLC:98.97%Couleur et forme :Transparent LiquidMasse moléculaire :144.8 kDa (Predicted)Reslizumab
CAS :Reslizumab (Sch 55700) is a humanized immunoglobulin G (IgG) 4 κ monoclonal antibody, thereby reducing eosinophil production and survival.Degré de pureté :98.1% (SDS-PAGE); 98.6% (SEC-HPLC) - 98.1% (SDS-PAGE); 98.6% (SEC-HPLC)Couleur et forme :LiquidMasse moléculaire :143.8 kDa (Predicted)RYTVELA TFA
CAS :RYTVELA TFA is a variant interleukin-1 receptor inhibitor with anti-inflammatory activity for the prevention of preterm labor and fetal protection.Formule :C38H62N10O12Couleur et forme :SolidMasse moléculaire :850.96Stapokibart
CAS :Stapokibart (CM310) is a humanized monoclonal antibody targeting IL-4Rα, blocking IL-4Rα-mediated signaling. It is used in studies of atopic dermatitis.Degré de pureté :96.09% (SEC-HPLC) - 96.09% (SEC-HPLC)Couleur et forme :LiquidMasse moléculaire :144.3 kDa (Predicted)Clazakizumab
CAS :Clazakizumab serves as a functional therapeutic tool specifically designed to enable the precise detection and neutralization of the circulating IL-6 protein which plays a pivotal role in the orchestration of chronic inflammation and immune dysregulation during strictly monitored laboratory observation periods and molecular investigations to evaluate the pharmacological potential of targeted cytokine blockade in specialized preclinical research environments to facilitate the development of novel immunotherapies.Degré de pureté :95%Couleur et forme :Transparent LiquidAnakinra
CAS :Anakinra (Raleukin) is an antagonist of recombinant, nonglycosylated human IL-1R. It is the first biological agent to block the pro-inflammatory effects.Formule :C759H1186N208O232S10Degré de pureté :95% - ≥95%Couleur et forme :SolidMasse moléculaire :17.3 kDaIL-17A antagonist 1
CAS :IL-17A antagonist 1 is an IL-17A antagonist for the study of interleukin-related inflammatory and immune diseases.Formule :C33H41FN6O4Degré de pureté :99.46%Couleur et forme :SolidMasse moléculaire :604.7148Anti-Human IL-17A Antibody
CAS :Anti-Human IL-17A (Secukinumab H chain) is a human monoclonal antibody targeting IL-17A, offering high affinity and low immunogenicity for psoriasis.Degré de pureté :98%Couleur et forme :LiquidMasse moléculaire :~150 kDaAnti-Mouse IL-4 Antibody (11B11)
Anti-Mouse IL-4 Antibody (11B11) is an inhibitory antibody targeting mouse IL-4, with the clone number 11B11.Degré de pureté :98.08% (SEC-HPLC) - 99%Couleur et forme :LiquidMasse moléculaire :~148 kDaCalcium acetate
CAS :Calcium acetate (Calcium ethanoate) attenuates PAH features in broiler models and suppresses TNFα-driven inflammatory and pyroptosis-associated markers in endothelial-lineage cells, informing vascular infFormule :C4H6CaO4Couleur et forme :SolidMasse moléculaire :158.17CNTO4088
CNTO4088 serves as a functional therapeutic tool specifically designed to enable the precise detection and neutralization of the interleukin-23 protein which plays a pivotal role in maintaining the chronic inflammatory state during strictly monitored laboratory observation periods and molecular biology investigations to evaluate the pharmacological efficacy of targeted cytokine modulation in specialized preclinical research environments to facilitate the study of adaptive immunity.Couleur et forme :Odour LiquidIMA-026
CAS :IMA-026 serves as a functional therapeutic tool specifically designed to enable the precise detection and neutralization of the interleukin-13 protein which plays a pivotal role in the pathogenesis of allergic asthma and chronic inflammatory disorders throughout the entire length of the designated laboratory study to evaluate the pharmacological efficacy of dual receptor blockade in specialized preclinical research environments.Anti-Human IL-13 Antibody (M1295)
Anti-IL-13 Antibody (M1295) is a functional neutralizing antibody against IL-13, inhibiting B cell activation and significantly reducing allergic inflammatory potential by blocking the cytokine signaling axis.YM-90709
CAS :YM-90709 is a new-type antagonist inhibiting the binding of interleukin-5 to the interleukin-5 receptor.Formule :C22H21N3O2Degré de pureté :99.94%Couleur et forme :Red SolidMasse moléculaire :359.42
